Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Debio 1450 for Bacterial Skin Infections

ClinicalTrials.gov ID: NCT02426918

Public ClinicalTrials.gov record NCT02426918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of 2 different doses of intravenous and oral Debio 1450 compared with intravenous vancomycin and oral linezolid in the treatment of patients with staphylococcal ABSSSI.

Study identification

NCT ID
NCT02426918
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Debiopharm International SA
Industry
Enrollment
330 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2015 (Type not available)
Primary completion
Aug 2016 (Actual)
Completion
Sep 2016 (Actual)
Last update posted
Nov 13, 2019

2015 – 2016

United States locations

U.S. sites
22
U.S. states
9
U.S. cities
20
Facility City State ZIP Site status
Dream Team Clinical Research, LLC Anaheim California 91776 —
Physician Alliance Research Center Anaheim California 92804 —
Southbay Pharma Research Buena Park California 90620 —
eStudySite - Chula Vista Chula Vista California 91911 —
eStudySite - La Mesa La Mesa California 91942 —
Long Beach Clinical Trials LLC Long Beach California 90806 —
Alliance Research Long Beach California 90813 —
Central Valley Research, LLC Modesto California 95350 —
eStudySite - Oceanside Oceanside California 92056 —
Olive View - UCLA Medical Center Sylmar California 91342 —
Shands Burn Center at the University of Florida Gainesville Florida 32610 —
Central Florida Internists Orlando Florida 32811 —
Triple O Research Institute West Palm Beach Florida 33401 —
Columbus Regional Research Columbus Georgia 31904 —
Beaumont Infectious Disease Services Royal Oak Michigan 48073 —
Mercury Street Medical Group PLLC Butte Montana 59701 —
eStudySite - Las Vegas Las Vegas Nevada 89109 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
Holy Name Medical Center Teaneck New Jersey 07666 —
ID Clinical Research, Ltd. Toledo Ohio 43608 —
East Montgomery County Clinic Houston Texas 77070 —
Tidwell Medical Center Splendora Texas 77372 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02426918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2019 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02426918 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →